Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study
Michael Gottlieb,Ralph C Wang,Huihui Yu,Erica S Spatz,Anna Marie Chang,Joann G Elmore,Paavali A Hannikainen,Mandy Hill,Ryan M Huebinger,Ahamed H Idris,Zhenqiu Lin,Katherine Koo,Samuel McDonald,Ian D Plumb,Michelle Santangelo,Sharon Saydah,Michael Willis,Lauren E Wisk,Arjun Venkatesh,Kari A Stephens,Robert A Weinstein,Robert A Weinstein,Michael Gottlieb,Michelle Santangelo,Katherine Koo,Antonia Derden,Michael Gottlieb,Kristyn Gatling,Diego Guzman,Geoffrey Yang,Marshall Kaadan,Minna Hassaballa,Ryan Jerger,Zohaib Ahmed,Michael Choi,Arjun Venkatesh,Erica Spatz,Zhenqiu Lin,Shu-Xia Li,Huihui Yu,Arjun Venkatesh,Erica Spatz,Andrew Ulrich,Jocelyn Dorney,Senyte Pierce,Xavier Puente,Graham Nichol,Kari Stephens,Jill Anderson,Dana Morse,Karen Adams,Zenoura Maat,Tracy Stober,Kelli N O'Laughlin,Nikki Gentile,Rachel E Geyer,Michael Willis,Luis Ruiz,Kerry Malone,Kristin Rising,Efrat Kean,Morgan Kelly,Kevin Schaeffer,Paavali Hannikainen,Lindsey Shughart,Hailey Shughart,Nicole Renzi,Grace Amadio,Dylan Grau,Phillip Watts,David Cheng,Jessica Miao,Carly Shutty,Alex Charlton,Mandy Hill,Summer Chavez,Arun Kane,Peter Nikonowicz,Ahamed H Idris,Samuel McDonald,David Gallegos,Riley Martin,Joann G Elmore,Lauren E Wisk,Michelle L'Hommedieu,Megan Eguchi,Kate Diaz Roldan,Raul Moreno,Ralph C Wang,Robin Kemball,Virginia Chan,Cecilia Lara Chavez,Angela Wong,Mireya Arreguin,Ian D Plumb,Aron J Hall,Sharon Saydah,Melissa Briggs-Hagen,Ralph Wang,Juan Carlos Montoy,Robert Rodriguez,Mengni Liu,Kari Black,Joann Elmore,Lauren Wisk,Chris Chandler,Nicole Villegas,Robert Rodriguez,Juan Carlos Montoy,For the INSPIRE Group
DOI: https://doi.org/10.1093/cid/ciad045
IF: 20.999
2023-01-29
Clinical Infectious Diseases
Abstract:Most research on SARS-CoV-2 variants focuses on initial symptomatology with limited data on longer-term sequelae. We sought to characterize the prevalence and differences in prolonged symptoms at three months post SARS-CoV-2-infection across the three major variant time-periods (pre-Delta, Delta, and Omicron). This multicenter prospective cohort study of adults with acute illness tested for SARS-CoV-2 compared fatigue severity, fatigue symptoms, individual and organ system-based symptoms, and presence of ≥3 total symptoms across variants among COVID-positive and COVID-negative participants 3 months after their initial SARS-CoV-2 diagnosis. Variant periods were defined by dates with ≥50% dominant strain. We performed a sensitivity analysis using ≥90% dominance threshold and multivariable logistic regression modeling to estimate the independent effects of each variant adjusting for socio-demographic characteristics, baseline health, and vaccine status. The study included 3,223 participants (2,402 COVID-positive and 821 COVID-negative). Among the COVID-positive cohort, 463 (19.3%) were pre-Delta, 1,198 (49.9%) during Delta, and 741 (30.8%) during Omicron. Prolonged severe fatigue was highest in the pre-Delta COVID-positive cohort compared with Delta and Omicron cohorts (16.7% vs 11.5% vs 12.3%, respectively; p = 0.017), as was presence of ≥3 prolonged symptoms (28.4% vs 21.7% vs 16.0%; p < 0.001). No difference was seen in the COVID-negative cohort between variant time-periods. In multivariable models, there was no difference in severe fatigue between variants. There was decreased odds of having ≥3 symptoms in Omicron compared with other variants; this was not significant after adjusting for vaccination status. Prolonged symptoms following SARS-CoV-2 infection were more common among participants infected during the pre-Delta period compared with Delta and Omicron periods; however, these differences were no longer significant after adjusting for vaccination status. This suggests a potential beneficial effect of vaccination on the risk of developing long-term symptoms.
immunology,infectious diseases,microbiology